“…An increase in SR activity, due to activation or the prevention of its degradation, may be promoted by the small ligands ATP and Mg 2+ (De Miranda et al, 2002 ; Strísovský et al, 2003 ; Foltyn et al, 2005 ), multiple protein interactors including GRIP, Golga3, Disc-1 and FBXO22 (Kim et al, 2005 ; Dumin et al, 2006 ; Ma et al, 2013 ; Dikopoltsev et al, 2014 ), by O-palmitoylation-related processes (Balan et al, 2009 ) and also possibly through phosphorylation at different residues (Balan et al, 2009 ; Foltyn et al, 2010 ). On the other hand, nicotinamide adeninedinucleotide (NADH) (Suzuki et al, 2015 ; Bruno et al, 2016 ), protein interactions with Pick-1 (Fujii et al, 2006 ), PSD-95 (Ma et al, 2014 ; Lin et al, 2016 ), SAP102 and stargazin (Ma et al, 2014 ), membrane or nuclear translocations (Balan et al, 2009 ; Kolodney et al, 2015 ) and S-Nitrosylation-related oxidative processes (Mustafa et al, 2007 ) inhibit SR activity. Therefore, the SR activity itself appears to be modulated in a complex manner by a large mosaic of mechanisms, which can be targeted by the aging process.…”